Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Methylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for Cabazitaxel from 10-DAB III. High yield, mild conditions. Cost-effective manufacturing solution for global supply chains.
Novel route for Gefitinib avoiding methanesulfonic acid demethylation, offering cost-effective API intermediate manufacturing solutions.
Patent CN117003642A reveals a novel route for Ensitrelvir intermediates. Achieve high purity and reduced costs with scalable pharmaceutical intermediate manufacturing strategies.
Solve low regioselectivity in trifluoromethylation. New copper-catalyzed method offers 70-83% yield, reducing production costs and supply chain risks for pharma R&D.